Zoetis agrees on $765M deal for aquaculture leader Pharmaq

Animal health leader Zoetis ($ZTS)--which has been the subject of many a pharma buyout rumor--is making a pickup of its own. Late Monday, the Pfizer ($PFE) spinoff announced an agreement to purchase Pharmaq--which specializes in vaccines and pharmaceuticals for farmed fish--for $765 million. Release

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.